Neurociencias
Departamento
Columbia University
Nueva York, Estados UnidosPublicaciones en colaboración con investigadoras/es de Columbia University (21)
2023
-
Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort
Movement Disorders, Vol. 38, Núm. 2, pp. 286-303
-
Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))
Nature communications
2022
-
Astrocyte-neuronal network interplay is disrupted in Alzheimer's disease mice
GLIA, Vol. 70, Núm. 2, pp. 368-378
-
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort
npj Parkinson's Disease, Vol. 8, Núm. 1
-
New insights into the genetic etiology of Alzheimer's disease and related dementias
Nature genetics, Vol. 54, Núm. 4, pp. 412-436
2021
-
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores
Nature communications, Vol. 12, Núm. 1, pp. 3417
-
Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
Nature Communications, Vol. 12, Núm. 1
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage
Nature Communications, Vol. 12, Núm. 1
2019
-
Absence of association between the level of lethality and the recidivism of suicide attempts in a Spanish province
Actas Espanolas de Psiquiatria, Vol. 47, Núm. 6, pp. 179-189
-
Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls
Movement Disorders, Vol. 34, Núm. 9, pp. 1392-1398
-
Cohort profile: Design and methods of the PREDIMED-Plus randomized trial
International Journal of Epidemiology, Vol. 48, Núm. 2, pp. 387-388o
-
Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)
Parkinsonism and Related Disorders, Vol. 62, pp. 201-209
-
SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease
Movement Disorders, Vol. 34, Núm. 9, pp. 1333-1344
2018
-
Aβ 1–42 triggers the generation of a retrograde signaling complex from sentinel mRNAs in axons
EMBO Reports, Vol. 19, Núm. 7
-
Mediterranean diet and quality of life: Baseline cross-sectional analysis of the PREDIMED-PLUS trial
PLoS ONE, Vol. 13, Núm. 6
2017
-
Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry
Movement Disorders, Vol. 32, Núm. 10, pp. 1432-1438
2015
-
Clinical correlations with lewy body pathology in LRRK2-related Parkinson disease
JAMA Neurology, Vol. 72, Núm. 1, pp. 100-105